Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
Go back to Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 143.04 -7.77 (5.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.81 | 52 Week High | $0.52 | |||
| Open | $145.95 | 52 Week Low | $0.08 | |||
| Day High | $150.20 | P/E | N/A | |||
| Day Low | $142.78 | EPS | $-3.80 | |||
| Volume | 7,225,493 | |||||
